Leading the Way in Cancer Detection, Treatment, and Prevention: The Center for BRCA and Related Genes

Mutations in BRCA (BReast CAncer) genes can be passed down from generation to generation, increasing the risk of developing breast cancer, as well as ovarian, pancreatic, and prostate cancers. Heritable BRCA mutations or mutations emerging in the tumors determine the tumor biology; this knowledge has been used to design effective and highly targeted therapies. In this educational webinar, the leaders of Dana-Farber’s Center for BRCA and Related Genes—one of the few dedicated BRCA centers worldwide—discuss how they are working to expand genetic testing for mutations, detect BRCA-related cancers earlier, and develop new therapies for patients with inherited and acquired mutations.

To learn more, visit the Revolutionary Science section of this site.

Give Now

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.

There has been an issue submitting your request. Please try again.

Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.